<DOC>
	<DOC>NCT00628953</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of Nexium in the treatment of subjects with persistent asthma believed to have acid reflux as a contributory factor to control of their asthma.</brief_summary>
	<brief_title>Adult Asthmatics and Acid Reflux</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Clinical diagnosis of asthma Forced Expiratory Volume and Peak Expiratory Flow as defined by the protocol Daily use of inhaled GCS and/or leukotriene pathway modifier for greater than 3 months. Severe heartburn 3 days/week during the runin period. Subjects with a history of 3 sinus infections treated with antibiotics in the year prior to Visit 1. Any other significant disease or pathology judged to be clinically significant by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Acid Reflux</keyword>
	<keyword>Nexium</keyword>
	<keyword>Esomeprazole</keyword>
</DOC>